Palo Alto, Calif.-based pharma company Neumentum said today that it raised $6 million in a Series A round through the sale of convertible preferred stock. The company plans to use its newly-acquired funds to advance two non-opioid drug products designed for pain management. Get the full story at our sister site, Drug Delivery Business News.
Funding Roundup
Robocath adds $2m for new neurovascular platform
Medical robotics startup Robocath said today that it added about $2 million (€1.7 million) to the more than $5 million it raised earlier this year, taking its total to $7.5 million in funding this year. Rouen, France-based Robocath, which is developing the R-One robotic platform for coronary angioplasty, is pursuing CE Mark approval in the European Union for […]
Titan Medical closes upsized $18m round
Titan Medical (TSX:TMD) said today that it closed a funding round that brought in nearly $4 million more than it was originally expecting, grossing more than $18 million for the Sport robot-assisted surgery device it’s developing. Last month the Toronto-based company upsizedthe previously announced offering to between $14.1 million and $18 million ((C$18 million to C$23 million), up from […]
HeartFlow stakes $90m step toward $150m Series E
HeartFlow took a $90 million step toward the $150 million it hopes to raise in a Series E round for the cardiac imaging technology it’s marketing. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across […]
Report: HeartFlow’s estimated $150m Series E would make it medtech’s latest unicorn
A reported Series E round for HeartFlow, estimated at $150 million, would value the company at more than $1 billion, vaulting it into unicorn territory. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across […]
Medpace prices $126m secondary offering
Medpace (NSDQ:MEDP) yesterday said affiliates of Cinven Capital Management are launching a secondary offering of 4 million shares of its common stock at $31.50 per share, for gross proceeds of $126 million – not including an underwriter’s option worth another $18.9 million. The offering includes a 30-day underwriters option to purchase an additional 600,000 shares, Cincinnati-based […]
Siemens plans Frankfurt listing for Healthineers business that could fetch $12B
Siemens (NYSE:SI) said this week that it’s planning to list its healthcare business on the Frankfurt Stock Exchange during the first half of 2018 in an initial public offering that could fetch nearly $12 billion. Siemens Healthineers, the German industrial conglomerate’s largest and most profitable division, is worth roughly $47.49 billion (€40 billion). The company plans […]
Biolase closes $12m rights offering
Biolase (NSDQ:BIOL) said today that it closed a rights offering that will bring in some $12 million for the dental laser maker. The offering, which expired at 5 pm Eastern yesterday, delivered subscriptions for some 26.3 million shares, Irvine, Calif.-based Biolase said. That’s about 5,000 more than planned, the company said. Biolase said it hoped to raise […]
Semma Therapeutics closes $114m round to advance cell therapy for Type I diabetes
Semma Therapeutics has closed an oversubscribed $114 million Series B round to help fund the development of its encapsulated stem cell-derived islet therapy for Type I diabetes. The Cambridge, Mass.-based company reported that it plans to use the newly-acquired funds to bring its cell therapy through clinical proof-of-concept studies, as well as explore other regenerative medicine […]
Fractyl raises $44m Series D for Revita DMR tech
Fractyl Laboratories said today that it raised $44 million in a Series D round, led by an undisclosed investor and first-time investors GV, True Ventures and the IDO Fund. Returning investors included Deerfield Management Company, Bessemer Venture Partners and others. The company said it plans to use the round’s proceeds to fund the continued development of […]
CHF Solutions prices $18m offering
CHF Solutions (NSDQ:CHFS) said today that it prices an offering of Series F stock and warrants worth $18.0 million. Eden Prairie, Minn.-based CHF Solutions, formerly known as Sunshine Heart, said the Series F shares are convertible to common stock at $4.50 per share. The Series F shares also carry a one-year Series 1 warrant for 223 shares […]